Back to Search

Randomized Phase II Trial of Anti-Lag-3 and Anti-PD-1 Blockade vs. SOC in Patients With Recurrent Glioblastoma


  • Protocol Number: 202411012
  • Principal Investigator: Johanns, Tanner
  • Cancer Types: Neurological

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions